We see four broad scenarios
Taking 2 grams of L-Carnitine and/or 3 to 6 grams of L-Glutamine per day has been recommended for exercise enhancement
Both companies demonstrate strong ESG management, particularly for product governance
Alternative weight management strategies, including other medications without thyroid concerns, should be considered for high-risk individuals
Since the first GLP-1R agonist, exenatide, was approved for the treatment of T2DM in 2005, a variety of GLP-1R agonists such as liraglutide and dulaglutide have been approved
With just about a week to go until 2026, Novo announced that its new weight loss pill under the brand name Wegovy had been approved in the U.S., making it the first oral GLP-1 treatment approved for weight loss